Cardiopulmonary Bypass has No Significant Impact on Survival in Patients Undergoing Nephrectomy and Level III-IV Inferior Vena Cava Thrombectomy: Multi-Institutional Analysis Academic Article uri icon

Overview

MeSH Major

  • Carcinoma, Renal Cell
  • Kidney Neoplasms
  • Neoplastic Cells, Circulating
  • Nephrectomy
  • Thrombectomy
  • Vena Cava, Inferior
  • Venous Thrombosis

abstract

  • In our multi-institutional analysis the use of cardiopulmonary bypass did not significantly impact cancer specific survival or overall survival in patients undergoing nephrectomy and level III or IV tumor thrombectomy. Neither approach was independently associated with increased mortality on multivariate analysis. Greater surgical complications were not independently associated with the use of cardiopulmonary bypass.

authors

publication date

  • January 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5012645

Digital Object Identifier (DOI)

  • 10.1016/j.juro.2015.02.2948

PubMed ID

  • 25797392

Additional Document Info

start page

  • 304

end page

  • 8

volume

  • 194

number

  • 2